CANCER

A randomised study of screening for colorectal cancer using faecal occult blood testing: results after 13 years and seven biennial screening rounds

O D Jørgensen¹, O Kronborg¹, C Fenger²

¹ Department of Surgical Gastroenterology, Odense University Hospital, Denmark
² Department of Pathology, Odense University Hospital, Denmark

Correspondence to:
Correspondence to:
Professor O Kronborg, Surgical Department A, Odense University Hospital, DK-5000 Odense C, Denmark;
Ole.kronborg{at}dadlnet.dk

Background: Three randomised trials have demonstrated reduction in mortality from colorectal cancer (CRC) by repeated screening with faecal occult blood tests, including the trial presented here, which is the only one still in progress.

Aims: To evaluate reduction in mortality after seven screening rounds and the possible influence of compliance on mortality from CRC.

Methods: At Funen in Denmark, random allocation to biennial screening with Hemoccult-II in 30 967 subjects aged 45–75 years and 30 966 controls was performed in 1985 from a population of 137 485 of the same age. Only participants who completed the first screening round were invited for further screening. Colonoscopy was offered if the test was positive. The primary end point was death from CRC, and the 10 year results were published in 1996.

Results: From the beginning of the first screening to the seventh round, mean age increased from 59.8 to 70.0 years in the screening and control groups, and the male/female ratio decreased from 0.92 to 0.81. Those who accepted screening were younger than non-responders. Positivity rates varied from 0.8% to 3.8%, the cumulative ratio of a positive test was 5.1% after seven rounds, and 4.8% of patients had at least one colonoscopy. Mortality from CRC was significantly less in the screening group (relative risk (RR) 0.82 (0.69–0.97)), and the reduction in mortality was most pronounced above the sigmoid colon. After seven rounds, RR was reduced to less than 0.70 compared with controls. Mortality rates from causes other than CRC did not differ. Non-responders had a significantly increased risk of death from CRC compared with those who accepted the full programme. Subjects who accepted the first screening, but not subsequent ones, demonstrated a tendency towards increased risk.

Conclusions: The persistent reduction in mortality from CRC in a biennial screening program with Hemoccult-II, and a reduction in RR to less than 0.70 in those adhering to the programme, support attempts to introduce larger scale population screening programmes. The smaller effect on mortality from CRC in the rectum and sigmoid colon suggests evaluation by additional flexible sigmoidoscopy with longer intervals.

Keywords: colorectal cancer; screening; faecal occult blood test

Abbreviations: H-II, Hemoccult-II; CRC, colorectal cancer; DCBE, double contrast barium enema; RR, relative risk

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• Rennert, G. (2009). Are We Getting Closer to Molecular Population Screening for Colorectal Cancer?. JNCI J Natl Cancer Inst 101: 902-903 [Full Text]  
• Costantini, A. S., Martini, A., Puliti, D., Ciatto, S., Castiglione, G., Grazzini, G., Zappa, M. (2008). Colorectal Cancer Mortality in Two Areas of Tuscany With Different Screening Exposures. JNCI J Natl Cancer Inst 100: 1818-1821 [Abstract] [Full Text]  
• Goulard, H., Boussac-Zarebska, M., Ancelle-Park, R., Bloch, J. (2008). French colorectal cancer screening pilot programme: results of the first round. J Med Screen 15: 143-148 [Abstract] [Full Text]  
• Galmiche, J P, Coron, E, Sacher-Huvelin, S (2008). Recent developments in capsule endoscopy. Gut 57: 695-703 [Full Text]  
• Han, M., Liew, C. T., Zhang, H. W., Chao, S., Zheng, R., Yip, K. T., Song, Z.-Y., Li, H. M., Geng, X. P., Zhu, L. X., Lin, J.-J., Marshall, K. W., Liew, C. C. (2008). Novel Blood-Based, Five-Gene Biomarker Set for the Detection of Colorectal Cancer. Clin. Cancer Res. 14: 455-460 [Abstract] [Full Text]  
• (2006). Population screening for colorectal cancer. DTB 44: 65-68 [Abstract] [Full Text]  
• Weissfeld, J. L., Schoen, R. E., Pinsky, P. F., Bresalier, R. S., Church, T., Yurgalevitch, S., Austin, J. H., Prorok, P. C., Gohagan, J. K., for the PLCO Project Team, (2005). Flexible Sigmoidoscopy in the PLCO Cancer Screening Trial: Results From the Baseline Screening Examination of a Randomized Trial. JNCI J Natl Cancer Inst 97: 989-997 [Abstract] [Full Text]  
• Collins, J. F., Lieberman, D. A., Durbin, T. E., Weiss, D. G., and the Veterans Affairs Cooperative Study #380 Gr, (2005). Accuracy of Screening for Fecal Occult Blood on a Single Stool Sample Obtained by Digital Rectal Examination: A Comparison with Recommended Sampling Practice. ANN INTERN MED 142: 81-85 [Abstract] [Full Text]  
• Hawk, E. T., Levin, B. (2005). Colorectal Cancer Prevention. JCO 23: 378-391 [Abstract] [Full Text]  
• Hoff, G, Grotmol, T, Thiis-Evensen, E, Bretthauer, M, Gondal, G, Vatn, M H (2004). Testing for faecal calprotectin (PhiCal) in the Norwegian Colorectal Cancer Prevention trial on flexible sigmoidoscopy screening: comparison with an immunochemical test for occult blood (FlexSure OBT). Gut 53: 1329-1333 [Abstract] [Full Text]  
• Hamilton, W., Sharp, D. (2004). Diagnosis of colorectal cancer in primary care: the evidence base for guidelines. Fam Pract 21: 99-106 [Abstract] [Full Text]  
• Lieberman, D. A., Prindiville, S., Weiss, D. G., Willett, W. (2003). Risk Factors for Advanced Colonic Neoplasia and Hyperplastic Polyps in Asymptomatic Individuals. JAMA 290: 2959-2967 [Abstract] [Full Text]  
• Walsh, J. M. E., Terdiman, J. P. (2003). Colorectal Cancer Screening: Scientific Review. JAMA 289: 1288-1296 [Abstract] [Full Text]  
• Schabas, R. E. (2003). Colorectal cancer screening in Canada: It's time to act. CMAJ 168: 178-179 [Full Text]  
• (2002). More Follow-Up on Fecal Occult Blood Screening for Colorectal Cancer. JWatch General 2002: 2-2 [Full Text]  
• (2002). Update: Danish Fecal Occult Blood Testing Trial. JWatch Gastroenterology 2002: 1-1 [Full Text]